Alzheimer’s: Canada’s Drug Agency recommends funding this drug to slow early stages CTV NewsHistoric Step for Alzheimer’s Care in Canada: CDA-AMC Recognizes Clinical Value of LEQEMBI® (lecanemab) and Recommends Public Coverage for Early Alzheimer’s Disease Yahoo Finance SingaporeCanada’s Drug Agency recommends funding lecanemab for early-stage Alzheimer’s disease Yahoo Lifestyle Canada
